Martin Bick

Martin Bick is a seasoned pharmaceutical executive with over 20 years of experience in market access, marketing, and pricing.

He possesses a profound understanding of specialty asset market access dynamics involving payers, physicians, practices, and patients, with a focus on the intersection of price and value.

His expertise extends to value-based contracts, Health Economic data generation, and Real World Evidence, with a strong knowledge base in US healthcare markets and global pricing and reimbursement strategy.

Known for his innovative strategies, Martin has a track record of adapting swiftly to regulatory changes and market dynamics, navigating complex organizational structures, and fostering external partnerships with major industry players such as Pfizer, Regeneron, and Sanofi.

With a background in managing cross-functional teams overseeing billions of dollars in assets, he is a skilled change management leader who has successfully led teams through reorganizations.

In addition to his corporate achievements, Martin is a staunch advocate of Diversity and Inclusion, employee development, and training to enhance team efficiency and performance.

His educational background includes a Master of Science from Stevens Institute of Technology, a certificate in Health Economics and Outcomes Research from the University of Washington, and a Bachelor of Arts from Montclair State University.